Central Nervous System Neoplasms

"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.

Descriptor ID	D016543
MeSH Number(s)	C04.588.614.250 C10.551.240
Concept/Terms	Central Nervous System Neoplasms Central Nervous System Neoplasms Neoplasms, Central Nervous System Tumors, Central Nervous System Central Nervous System Tumors Central Nervous System Neoplasms, Primary Central Nervous System Neoplasms, Primary Primary Central Nervous System Neoplasms

Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Nervous System Diseases [C10]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]

Below are MeSH descriptors whose meaning is related to "Central Nervous System Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in this website by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.

Bar chart showing 29 publications over 17 distinct years, with a maximum of 4 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	0	1
2002	1	0	1
2003	1	0	1
2004	2	1	3
2008	2	0	2
2009	1	1	2
2010	1	1	2
2013	0	1	1
2014	1	0	1
2015	4	0	4
2016	2	0	2
2018	1	1	2
2022	1	0	1
2023	2	0	2
2024	0	1	1
2025	1	0	1

Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles.

Silverman RF, Abramson DH, Canestraro J, Grommes C, Francis JH. Vitreoretinal lymphoma: the importance of cerebral spinal fluid evaluation at initial diagnosis. Br J Ophthalmol. 2025 Mar 20; 109(4):504-509.

View in: PubMed
Pascual-Pasto G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, Hofmann TJ, Burgue?o V, Harvey K, Martinez D, Shah AC, Foster JB, Pogoriler J, Eagle RC, Carcaboso AM, Shields CL, Leahey AM, Bosse KR. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clin Cancer Res. 2024 Aug 15; 30(16):3578-3591.

View in: PubMed
Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Transplant Cell Ther. 2023 06; 29(6):380.e1-380.e9.

View in: PubMed
Lin R, Kenyon A, Wang ZX, Cai J, Iacovitti L, Kenyon LC. Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion. Neuropathology. 2023 Oct; 43(5):391-395.

View in: PubMed
Andolina JR, Fries C, Boulware R, Vargas A, Fraint E, Barth M, Ambrusko S, Comito M, Monteleone P. Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e264-e267.

View in: PubMed
Tun HW, Johnston PB, DeAngelis LM, Atherton PJ, Pederson LD, Koenig PA, Reeder CB, Omuro AMP, Schiff D, O'Neill B, Pulido J, Jaeckle KA, Grommes C, Witzig TE. Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma. Blood. 2018 11 22; 132(21):2240-2248.

View in: PubMed
Holmes L, Chavan P, Blake T, Dabney K. Unequal Cumulative Incidence and Mortality Outcome in Childhood Brain and Central Nervous System Malignancy in the USA. J Racial Ethn Health Disparities. 2018 10; 5(5):1131-1141.

View in: PubMed
Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP. Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. J Clin Oncol. 2016 05 10; 34(14):1620-5.

View in: PubMed
Shanbhogue KP, Hoch M, Fatterpaker G, Chandarana H. von Hippel-Lindau Disease: Review of Genetics and Imaging. Radiol Clin North Am. 2016 May; 54(3):409-22.

View in: PubMed
Suresh S, Abel AS, Younge BR, Bilyk JR, Lee MS. Masses in the membranes. Surv Ophthalmol. 2016 May-Jun; 61(3):357-62.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement